Karen Narwold - Ingevity Corp Independent Director
| NGVT Stock | USD 48.51 0.64 1.34% |
Director
Ms. Karen G. Narwold is Independent Director of the Company. Ms. Narwold has over 25 years of experience at industrial and chemical companies. She currently serves as Executive Vice President, Chief Administrative Officer, General Counsel and Corporationrationrate Secretary of Albemarle Corporationrationration, a global specialty chemicals company, since 2010. In this role, she leads the Company legal, public affairs, IT, and compliance organizations. She is also a member of Albemarle Enterprise Risk Management and Disclosure Committees. Ms. Narwold previously served as Advisor at Symmetry Advisors from 2009 to 2010, and as General Counsel in 2007 to Symmetry Holdings. She also served in various leadership roles at Barzel Industries from 2008 to 2009, including Vice President, Chief Administrative Officer and General Counsel. Ms. Narwold commenced her professional career with five years in private legal practice, followed by 16 years in roles of increasing leadership responsibilities with GrafTech International, a carbon and graphite producer since 2019.
| Age | 61 |
| Tenure | 5 years |
| Address | 4920 O'Hear Avenue, North Charleston, SC, United States, 29405 |
| Phone | 843 740 2300 |
| Web | https://www.ingevity.com |
Ingevity Corp Management Efficiency
The company has return on total asset (ROA) of 0.0597 % which means that it generated a profit of $0.0597 on every $100 spent on assets. This is way below average. Ingevity Corp's management efficiency ratios could be used to measure how well Ingevity Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.003 in 2024. Return On Capital Employed is likely to drop to 0.11 in 2024. Change To Liabilities is likely to gain to about 51.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 219 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mark Douglas | Quaker Chemical | 58 | |
| David Hodnik | Sherwin Williams Co | 71 | |
| Michael Shannon | Quaker Chemical | 60 | |
| Sanjay Hinduja | Quaker Chemical | 56 | |
| WILLIAM Cook | Quaker Chemical | 72 | |
| Robert Rock | Quaker Chemical | 70 | |
| John Stropki | Sherwin Williams Co | 67 | |
| Donald Caldwell | Quaker Chemical | 74 | |
| Michael Thaman | Sherwin Williams Co | 57 | |
| Arthur Anton | Sherwin Williams Co | 63 | |
| Melissa McClain | Quaker Chemical | N/A | |
| Jeffry Frisby | Quaker Chemical | 65 | |
| Patricia Barron | Quaker Chemical | 72 | |
| Richard Kramer | Sherwin Williams Co | 57 | |
| Matthew Thornton | Sherwin Williams Co | 62 | |
| Steven Wunning | Sherwin Williams Co | 69 | |
| Richard Smucker | Sherwin Williams Co | 66 | |
| Fay West | Quaker Chemical | 52 | |
| Kerrii Anderson | Sherwin Williams Co | 63 | |
| Susan Kropf | Sherwin Williams Co | 71 | |
| Christine Poon | Sherwin Williams Co | 68 | |
Management Performance
| Return On Equity | -0.0081 | ||||
| Return On Asset | 0.0597 |
Ingevity Corp Leadership Team
Elected by the shareholders, the Ingevity Corp's board of directors comprises two types of representatives: Ingevity Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingevity. The board's role is to monitor Ingevity Corp's management team and ensure that shareholders' interests are well served. Ingevity Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingevity Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| J Fitzpatrick, Independent Director | ||
| Michael Wilson, President CEO, Director | ||
| John Nypaver, VP Relations | ||
| Katherine Burgeson, Senior Vice President General Counsel, Secretary | ||
| Phillip Platt, Co Officer | ||
| John Fortson, President, Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Director | ||
| Mary Hall, Chief Financial Officer, Executive Vice President, Treasurer | ||
| Frederick Lynch, Lead Independent Director | ||
| Luis FernandezMoreno, Independent Director | ||
| Richard White, Senior Chemicals | ||
| Dan Gallagher, Vice President Financial Planning & Analysis and Investor Relations | ||
| Michael Smith, Executive Vice President and President Performance Chemicals, Strategy and Business Development | ||
| Diane Gulyas, Independent Director | ||
| Michael Fitzpatrick, Independent Director | ||
| Erik Ripple, VP Officer | ||
| S Woodcock, Executive Vice President and President - Performance Materials | ||
| Steve Hulme, Senior Vice President - Performance Chemicals, and President Engineered Polymers | ||
| Edward Woodcock, Senior Vice President and President of Performance Materials | ||
| Richard Kelson, Independent Chairman of the Board | ||
| Stacy Cozad, Executive Vice President General Counsel, Company Secretary | ||
| Stuart Woodcock, Executive Materials | ||
| Daniel Sansone, Independent Director | ||
| Christine Stunyo, Senior Officer | ||
| Jean Blackwell, Independent Chairman of the Board | ||
| Ryan Fisher, Vice President, Deputy General Counsel | ||
| Karen Narwold, Independent Director | ||
| Rich White, Senior Vice President - Performance Chemicals, and President Industrial Specialties and Pavement Technologies | ||
| Caroline Monahan, Director Communications | ||
| Daniel Gallagher, VP Relations | ||
| Steven Hulme, Senior Technologies | ||
| Edward Rose, Executive Vice President and President of Performance Chemicals |
Ingevity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ingevity Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0081 | ||||
| Return On Asset | 0.0597 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 3.2 B | ||||
| Shares Outstanding | 36.28 M | ||||
| Shares Owned By Insiders | 0.74 % | ||||
| Shares Owned By Institutions | 93.50 % | ||||
| Number Of Shares Shorted | 684.52 K | ||||
| Price To Earning | 16.90 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Ingevity Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Ingevity Stock please use our How to Invest in Ingevity Corp guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Ingevity Stock analysis
When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Ingevity Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ingevity Corp. If investors know Ingevity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ingevity Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Earnings Share (0.15) | Revenue Per Share 46.364 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0597 |
The market value of Ingevity Corp is measured differently than its book value, which is the value of Ingevity that is recorded on the company's balance sheet. Investors also form their own opinion of Ingevity Corp's value that differs from its market value or its book value, called intrinsic value, which is Ingevity Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ingevity Corp's market value can be influenced by many factors that don't directly affect Ingevity Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ingevity Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ingevity Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ingevity Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.